Definium Therapeutics, Inc. (DFTX) Current Ratio
- Current ratio · latest quarter: Value 6.95×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.95× | Current assets / current liabilities. $1.09B ÷ $157.20M ≈ 6.95× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.09B USD | Assets, Current |
| Current obligations | 157.20M USD | Liabilities, Current |
| Cash and equivalents | 655.27M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 6.96M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.09B | $157.20M | $655.27M | (m) | (m) | (m) | $6.96M | (m) | 6.95× |
| 2026-03-31 | $380.56M | $81.11M | $262.52M | (m) | (m) | (m) | $7.13M | (m) | 4.69× |
| 2025-12-31 | $419.32M | $66.70M | $257.84M | (m) | (m) | (m) | $5.35M | (m) | 6.29× |
| 2025-09-30 | $215.85M | $65.42M | $19.96M | (m) | (m) | (m) | $8.11M | (m) | 3.30× |
| 2025-06-30 | $189.14M | $37.96M | $33.39M | (m) | (m) | (m) | $4.22M | (m) | 4.98× |
| 2025-03-31 | $221.70M | $30.48M | $82.85M | (m) | (m) | (m) | $2.27M | (m) | 7.27× |
| 2024-12-31 | $281.62M | $38.85M | $273.74M | (m) | (m) | (m) | $2.01M | (m) | 7.25× |
| 2024-09-30 | $299.36M | $33.27M | $295.28M | (m) | (m) | (m) | $2.15M | (m) | 9.00× |
| 2024-06-30 | $247.69M | $41.85M | $243.13M | (m) | (m) | (m) | $2.94M | (m) | 5.92× |
| 2024-03-31 | $255.47M | $65.27M | $252.33M | (m) | (m) | (m) | $7.59M | (m) | 3.91× |
| 2023-12-31 | $103.87M | $32.25M | $99.70M | (m) | (m) | (m) | $4.14M | (m) | 3.22× |
| 2023-09-30 | $120.09M | $31.15M | $117.70M | (m) | (m) | (m) | $7.69M | (m) | 3.85× |
| 2023-06-30 | $119.79M | $35.12M | $116.89M | (m) | (m) | (m) | $8.58M | (m) | 3.41× |
| 2023-03-31 | $132.41M | $24.10M | $129.41M | (m) | (m) | (m) | $2.32M | (m) | 5.50× |
| 2022-12-31 | $146.06M | $17.89M | $142.14M | (m) | (m) | (m) | $2.11M | (m) | 8.16× |
| 2022-09-30 | $156.51M | $26.04M | $154.52M | (m) | (m) | (m) | $824.00K | (m) | 6.01× |
| 2022-06-30 | $109.09M | $7.87M | $105.74M | (m) | (m) | (m) | $732.00K | (m) | 13.86× |
| 2022-03-31 | $123.23M | $10.56M | $120.47M | (m) | (m) | (m) | $3.33M | (m) | 11.67× |
| 2021-12-31 | $137.22M | $10.41M | $133.54M | (m) | (m) | (m) | $4.18M | (m) | 13.18× |
| 2020-12-31 | $81.52M | $3.01M | $80.09M | (m) | (m) | (m) | $2.02M | (m) | 27.10× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |